Regis Healthcare Ltd (ASX: REG) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Regis Healthcare Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$1.32 billion
P/E Ratio
23.88
Dividend Yield
4.19%
Shares Outstanding
302.46 million
Earnings per share
0.184
Dividend per share
0.19
Year To Date Return
-34.19%
Earnings Yield
4.19%
Franking
100%
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Regis Healthcare Ltd (ASX: REG)
Latest News
Cheap Shares
2 ASX shares tipped to grow up to 55% or more in the next 12 months
Healthcare Shares
1 ASX dividend stock down 49% I'd buy right now
Cheap Shares
2 ASX shares tipped to grow 30% or more in the next 12 months
Broker Notes
9 ASX shares downgraded by experts post-results this week
Dividend Investing
40 ASX shares with ex-dividend dates next week
Healthcare Shares
Regis Healthcare reacts to government funding change
Healthcare Shares
Regis Healthcare reports higher FY26 profits and dividend
Healthcare Shares
Regis Healthcare acquires Royal Freemasons' Victorian home care business
Blue Chip Shares
The ageing Australia megatrend: 3 ASX shares built to benefit
ASX Share Market News
What are experts saying about these ASX 200 stocks soaring higher today?
Healthcare Shares
Regis Healthcare expects FY26 EBITDA to hit top end of guidance
Healthcare Shares
Regis Healthcare names Andrew Kinkade as new CEO
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 08 Sep 2026 | $0.0940 | 100.00% | Final | 23 Sep 2026 |
| 12 Mar 2026 | $0.0900 | 100.00% | Interim | 09 Apr 2026 |
| 09 Sep 2025 | $0.0813 | 69.99% | Final | 24 Sep 2025 |
| 13 Mar 2025 | $0.0809 | 59.95% | Interim | 10 Apr 2025 |
| 10 Sep 2024 | $0.0664 | 50.00% | Final | 25 Sep 2024 |
| 14 Mar 2024 | $0.0628 | 50.00% | Interim | 11 Apr 2024 |
| 12 Sep 2023 | $0.0748 | 50.00% | Final | 27 Sep 2023 |
| 16 Mar 2023 | $0.0200 | 50.00% | Interim | 14 Apr 2023 |
| 15 Sep 2022 | $0.0232 | 50.00% | Final | 30 Sep 2022 |
| 10 Mar 2022 | $0.0352 | 50.00% | Interim | 08 Apr 2022 |
| 15 Sep 2021 | $0.0463 | 50.11% | Final | 30 Sep 2021 |
| 10 Mar 2021 | $0.0200 | 50.00% | Interim | 08 Apr 2021 |
| 11 Mar 2020 | $0.0402 | 50.00% | Interim | 30 Sep 2020 |
| 11 Sep 2019 | $0.0711 | 100.00% | Final | 26 Sep 2019 |
| 13 Mar 2019 | $0.0812 | 100.00% | Interim | 11 Apr 2019 |
| 11 Sep 2018 | $0.0865 | 100.00% | Final | 26 Sep 2018 |
| 13 Mar 2018 | $0.0928 | 100.00% | Interim | 11 Apr 2018 |
| 01 Sep 2017 | $0.0000 | 100.00% | Final | 18 Sep 2017 |
| 03 Mar 2017 | $0.1030 | 100.00% | Interim | 20 Mar 2017 |
| 02 Sep 2016 | $0.0594 | 100.00% | Final | 19 Sep 2016 |
| 03 Mar 2016 | $0.0940 | 100.00% | Interim | 21 Mar 2016 |
| 03 Mar 2004 | $0.0700 | 100.00% | Interim | 24 Mar 2004 |
REG ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Regis Healthcare Ltd
Regis Healthcare Ltd. engages in the provision of residential aged care services. It offers aged care facilities, retirement villages, home care, day therapy, and day respite program. The company operates through the following segments: Aged Care, Retirement Living and Home Care. Regis Healthcare was founded by Bryan Dorman and Ian Roberts in 1994 and is headquartered in Melbourne, Australia.
REG Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 14 Oct 2026 | $4.35 | $-0.04 | -0.91% | 594,964 | $4.49 | $4.49 | $4.32 |
| 13 Oct 2026 | $4.39 | $-0.06 | -1.35% | 768,803 | $4.50 | $4.52 | $4.36 |
| 12 Oct 2026 | $4.45 | $0.06 | 1.37% | 576,711 | $4.39 | $4.50 | $4.38 |
| 09 Oct 2026 | $4.39 | $0.06 | 1.39% | 503,649 | $4.31 | $4.41 | $4.30 |
| 08 Oct 2026 | $4.33 | $-0.02 | -0.46% | 453,082 | $4.32 | $4.36 | $4.29 |
| 07 Oct 2026 | $4.35 | $0.02 | 0.46% | 493,728 | $4.30 | $4.38 | $4.30 |
| 06 Oct 2026 | $4.33 | $-0.03 | -0.69% | 519,458 | $4.35 | $4.44 | $4.32 |
| 05 Oct 2026 | $4.36 | $-0.07 | -1.58% | 559,485 | $4.45 | $4.50 | $4.36 |
| 02 Oct 2026 | $4.43 | $0.06 | 1.37% | 715,177 | $4.38 | $4.48 | $4.37 |
| 01 Oct 2026 | $4.37 | $0.06 | 1.39% | 965,203 | $4.35 | $4.43 | $4.22 |
| 30 Sep 2026 | $4.31 | $-0.12 | -2.71% | 3,858,434 | $4.42 | $4.45 | $4.31 |
| 29 Sep 2026 | $4.43 | $-0.05 | -1.12% | 1,277,301 | $4.51 | $4.55 | $4.42 |
| 28 Sep 2026 | $4.48 | $0.02 | 0.45% | 1,458,344 | $4.50 | $4.53 | $4.41 |
| 25 Sep 2026 | $4.46 | $-0.19 | -4.09% | 1,055,613 | $4.65 | $4.65 | $4.46 |
| 24 Sep 2026 | $4.65 | $-0.08 | -1.69% | 701,185 | $4.68 | $4.69 | $4.61 |
| 23 Sep 2026 | $4.73 | $-0.04 | -0.84% | 915,888 | $4.80 | $4.86 | $4.73 |
| 22 Sep 2026 | $4.77 | $0.00 | 0.00% | 523,855 | $4.78 | $4.86 | $4.71 |
| 21 Sep 2026 | $4.77 | $0.06 | 1.27% | 531,337 | $4.76 | $4.80 | $4.70 |
| 18 Sep 2026 | $4.71 | $-0.09 | -1.88% | 2,017,979 | $4.78 | $4.84 | $4.69 |
| 17 Sep 2026 | $4.80 | $0.19 | 4.12% | 878,268 | $4.57 | $4.84 | $4.57 |
| 16 Sep 2026 | $4.61 | $0.09 | 1.99% | 1,336,720 | $4.47 | $4.65 | $4.46 |
| 15 Sep 2026 | $4.52 | $-0.10 | -2.16% | 819,008 | $4.64 | $4.65 | $4.52 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 08 Sep 2026 | Ian Roberts | Buy | 54,405 | $250,617 |
On-market trade. average price of $4.606523, As per announcement
|
| 04 Sep 2026 | Graham Hodges | Buy | 20,000 | $89,963 |
On-market trade.
|
| 04 Sep 2026 | Sally Freeman | Buy | 14,318 | $62,447 |
On-market trade.
|
| 31 Aug 2026 | Andrew Kinkade | Buy | 40,000 | $245,832 |
On-market trade.
|
| 28 Aug 2026 | Carmel Monaghan | Buy | 6,430 | $39,415 |
On-market trade.
|
| 19 Jun 2026 | Linda Mellors | Transfer | 284,270 | $1,745,417 |
Off-market transfer. Assuming off market transfer, As per announcement
|
| 19 Jun 2026 | Linda Mellors | Transfer | 284,270 | $1,745,417 |
Off-market transfer. Assuming off market transfer, As per announcement
|
| 11 Jun 2026 | Ian Roberts | Transfer | 13,699 | $82,467 |
As advised by the company. held by Yackandan Pty Ltd as trustee for the Leggatt Retirement Trust was transferred to MCTF Pty Ltd.
|
| 04 May 2026 | Linda Mellors | Sell | 223,950 | $1,491,977 |
On-market trade. As per announcement
|
| 25 Feb 2026 | Carmel Monaghan | Buy | 2,200 | $15,164 |
On-market trade.
|
| 03 Dec 2025 | Linda Mellors | Issued | 115,236 | $916,126 |
Issue of securities. 629,324 Rights. No cash consideration is payable. 115,236 Performance Rights issued under the FY26 LTI plan.
|
| 17 Oct 2025 | Linda Mellors | Cancelled | 4,688 | $30,237 |
Cancellation of securities. 514,088 Rights
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Graham Hodges | Non-Executive DirectorNon-Executive Chairman | Aug 2017 |
Mr Hodges has 40 years' experience in the financial services industry. Mr Hodges built an executive career at the Australian and New Zealand Banking Group
Limited and was formerly the Deputy Chief Executive Officer, ANZ Banking Group Ltd. Mr Hodges is a member of People Committee and Risk and Compliance Committee. |
| Professor Christine Constance Bennett | Non-Executive Director | Mar 2018 |
Prof Bennett has 30 years of health industry experience in clinical care and governance, strategy, executive management, advocacy, teaching and research. Prof Bennett is a Patron of Research Australia and on the Board of the Australian Digital Health Agency. Prof Bennett is Chair of the Clinical Governance and Care Committee, Member of the Risk and Compliance Committee and Member of the Property Committee.
|
| Mr Ian Gregory Roberts | Non-Executive Director | May 2007 |
Mr Roberts has 35 years of experience in the real estate sector including 25 years in residential aged care. Mr Roberts is a Non-Executive Director of several property and property services enterprises. Mr Roberts is Chair of Property Committee and Member of the People Committee.
|
| Ms Jodie Lee Leonard | Non-Executive Director | Nov 2023 |
Ms Leonard has 30 years' experience in ASX, NYSE and FTSE-listed companies and includes senior positions at General Electric, the Nine Network, British Airways and Telstra, having worked across Australia, the USA, UK, Asia and Europe. Ms Leonard has experience in a diverse range of industries including banking and financial services, superannuation, healthcare, technology, consumer goods, media and entertainment, and travel and tourism.
|
| Ms Sally Margaret Freeman | Non-Executive Director | Jan 2022 |
Ms Freeman has experience in Governance, Risk, and Audit, with an executive career spanning 30 years, culminating in being the Partner in Charge of KPMG Australia's Risk Consulting practice and a member of KPMG's Global Risk Executive. Ms Freeman is Chair of the Risk and Compliance Committee, Member of the People, Committee and Member of the Clinical Governance and Care Committee.
|
| Ms Carmel Anne Monaghan | Non-Executive Director | Feb 2026 |
Ms Monaghan has experience in healthcare governance, quality and safety oversight, and navigating complex regulatory environments. Ms Monaghan served on Ramsay affiliated boards both in Australia and overseas, as well as being Vice President of the Australian Private Hospitals Association. Ms Monaghan is member of the Property Committee and member of the Clinical Governance and Care Committee.
|
| Mr Andrew John Kinkade | Chief Executive OfficerManaging Director | Jul 2026 |
Mr Kinkade is an executive with more than 20 years experience spanning aged care, healthcare, private equity and investment banking. He is currently Managing Director of Bupa Villages & Aged Care. Prior to Bupa Aged Care, Andrew held executive healthcare roles at Bupa Dental Care, Catholic Healthcare and National Home Doctor Service. Earlier roles included strategy consulting at Bain & Company and Macquarie Group, where he worked in private equity, asset management and investment banking in London.
|
| Mr Malcolm Peter Ross | Company SecretaryGeneral Counsel | Nov 2021 |
-
|
| Rick Rostolis | Chief Financial Officer |
-
|
|
| Dr Imtiaz Bhayat | Chief Information Officer |
-
|
|
| Jenn Armor | Chief Operating Officer |
-
|
|
| Jodie Haydon | Chief People Officer |
-
|
|
| Malcolm Peter Ross | Company SecretaryGeneral Counsel |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Galabay Pty Ltd ACN 010 849 153 | 81,910,479 | 27.09% |
| HSBC Custody Nominees (Australia) Limited (i) | 58,365,368 | 19.30% |
| J P Morgan Nominees Australia Pty Limited | 44,314,982 | 14.66% |
| Citicorp Nominees Pty Limited | 38,682,858 | 12.79% |
| Ashburn Pty Ltd ACN 005 883 438 | 32,205,238 | 10.65% |
| BNP Paribas Noms Pty Ltd (i) | 8,148,952 | 2.70% |
| Mandala Holdings Pty Ltd | 3,248,000 | 1.07% |
| HSBC Custody Nominees (Australia) Limited (ii) | 2,296,146 | 0.76% |
| Bki Investment Company Limited | 1,807,428 | 0.60% |
| UBS Nominees Pty Ltd | 1,654,316 | 0.55% |
| Warbont Nominees Pty Ltd (i) | 1,651,030 | 0.55% |
| Mr Vincent Michael O'Sullivan | 1,290,000 | 0.43% |
| BNP Paribas Nominees Pty Ltd (i) | 1,264,842 | 0.42% |
| BNP Paribas Nominees Pty Ltd (ii) | 956,458 | 0.32% |
| Sandhurst Trustees Ltd | 680,000 | 0.22% |
| Mutual Trust Pty Ltd | 600,000 | 0.20% |
| HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED A/C 2 | 537,982 | 0.18% |
| Mr Ross James Johnston | 528,453 | 0.17% |
| Warbont Nominees Pty Ltd (ii) | 427,346 | 0.14% |
| BNP Paribas Noms Pty Ltd (ii) | 339,702 | 0.11% |
